13. anti retroviral
-
Upload
vijay-prasad-sanghishetti -
Category
Health & Medicine
-
view
483 -
download
6
description
Transcript of 13. anti retroviral
![Page 1: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/1.jpg)
Human Immunodeficiency Virus
• HIV is a Retrovirus which means:– It contains a single-stranded RNA genome– HIV will incorporate it’s genome into it’s host cell – hijack the normal functions of the cell to replicate – This process will eventually lead to cell destruction
• The target for HIV is the CD-4+ Helper T-Cells, which are the backbone of the immune system.
• First recognized in 1981 June 5th
![Page 2: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/2.jpg)
Immunity Macrophages lymphocytesNatural killer cells
T CELLS B CELLS
CLONE PROLIFERATE
ANTIGEN DESTRUCTION IgG(INNATE IMMUNITY) IgM
IgA, E, D
SUPPRESOR (CD8) CYTOTOXIC (CD8) HELPER(CD4)
cellmediated immunity Humoral
![Page 3: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/3.jpg)
Disease staging system for HIVAccording to the WHO• Stage I- infection asymptomatic and not categorized as
AIDS, expect presence of lymphadenopathy• Stage II- Minor mucocutaneous infections and recurrent
URTI• Stage III- Unexplained chronic diarrhea for longer than
1month, weight loss, several bacterial infections, pulmonary infections
• Stage IV- Toxoplasmosis of the brain, candidiasis of esophagous, trachea, bronchi, lungs. All of indicate AIDS
![Page 4: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/4.jpg)
Symptoms
• The Majority of Symptoms of an HIV infection do not show up until the disease has already begun to damage the immune system
• The incubation time for an HIV infection can be several weeks to several years
![Page 5: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/5.jpg)
• General symptoms :– Lack of energy– Weight loss– Frequent fevers – Sweats – Persistent or frequent fungal infections– Persistent skin rashes – Flakey skin and mouth, – Genital or anal sores from Herpes infections
![Page 6: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/6.jpg)
Opportunistic Infections
• HIV infection is usually discovered when a patient is diagnosed with an unusually severe or persistent infection
• Opportunistic infections include:– Bacterial, Fungal, Parasitic, and Viral Infections
• These infections will be more severe because the person’s immune system suppressed.
![Page 7: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/7.jpg)
Retrovirusgp140
gp 41
Core proteins
RT
Protease
integrease
![Page 8: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/8.jpg)
Replication rate 1010/day, 109 CD cells destroyed , half life 1-2h in plasma, 1.5days in infected CD cells, in latently infected cells 12months
![Page 9: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/9.jpg)
HIV replication
![Page 10: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/10.jpg)
Drug treatment for HIV
• Currently no vaccine, no cure• Mostly drugs are postponing complications of
acquired immunodeficiency syndrome & AIDS related complications .
![Page 11: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/11.jpg)
January 2011 11www.aidsetc.org
Goals of Treatment
• Improve quality of life• Reduce HIV-related morbidity and mortality • Restore and/or preserve immunologic function• Maximally and durably suppress HIV viral load• Prevent HIV transmission• Inc. CD4 count• Dec. drug resistance
• Inc. 5-8yr of life span
![Page 12: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/12.jpg)
Anti-HIV drugs
• Nucleoside reverse transcriptase inhibitors (NRTIs)
• Nucleotide Reverse Transcriptase Inhibitors (NtRTIs)
• Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
• Protease inhibitor ( PI )• Fusion inhibitor
![Page 13: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/13.jpg)
DRUG THERAPY OF HIV INFECTION• Entry /Fusion inhibitor
Enfuvirtide• Nucleoside reverse transcriptase inhibitors (NRTIS)
Zidovidine Stavudine Lamivudine AbacavirZalcitabine Didanosine Emtricitabine
• Non Nucleoside reverse transcriptase inhibitors (NNRTIS)
Efavirenz Nevirapine Delaviridine• Necleotide reverse transcriptase inhibitors (NTRTIS)
Tenofovir• Protease Inhibitors(PIs)
Saquinvir Indanavir Nelfinvir Amprenavir Ritonavir Lopinavir Atazanavir Fosamprenavir
![Page 14: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/14.jpg)
Newer drugs
• CCR 5 chemokine receptor inhibitor: Maraviroc• Integrase inhibitors : Raltegravir
![Page 15: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/15.jpg)
Problems with drug therapy
• Majority drugs have serious adverse effects• More drug interaction• Have to be taken for life long• HIV can’t be eradicated • HIV viruses have high mutation rate, cross
resistance • Many drugs block the infection of the new cells
rather than treating the already infected cells
![Page 16: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/16.jpg)
Nucleoside reverse transcriptase inhibitors (NRTIS)
• 1985 – research on anti-viral medication begins• 1987 – First drug Zidovudine produced– First NRTI– Early life extending properties
General mechanism• First converted into triphosphate derivatives
by host cell kinase enzymes• NRTIs are phosphorylated three times after
they enter the cell to become successful inhibitors
![Page 17: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/17.jpg)
General therapeutic uses
• Generally used in combination with other drugs (PIs) to avoid devp. of resistance (NRTI)
• Multi drug therapy is need to counter act • Combination synergetic action• Sequential blockade • Highly Active Anti Retroviral Therapy(HAART)
NRTIs(2) + PI Or
NRTIs(1) + NNRTIs(1) + PI(1)Or
NRTIs(1) + NNRTIs(1) + PI(2)
![Page 18: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/18.jpg)
![Page 19: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/19.jpg)
Adverse Effects: NRTIs
• All NRTIs: – Lactic acidosis and hepatomegaly due to
mitochondrial damage – Lipodystrophy
![Page 20: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/20.jpg)
zidovudine
• Zidovudine first drug. • Approved by the FDA on March 20, 1987 and is
thymidine analogue (HIV1 &2, T- cell lympho trophic virus)
• Inhibits RT and causes chain termination• Used for post exposure prophylaxis• It reduces the incidence of neonatal HIV infection
(100mg , 5 times a day) to HIV infected mother after 14weeks of gestation until birth
• New born receive syrup 2mg/kg 6hrly from birth to six week of age
![Page 21: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/21.jpg)
• Clinical uses:-• ↓mortality & opportunistic infections• gain weight• better quality of life• delays signs and symptoms of AIDS
• Adverse effect:• Toxicity: Bone marrow suppression – Granulocytopenia and anemia: 45% – Severe headache, nausea, insomnia, myalgias
![Page 22: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/22.jpg)
Lamivudine
• Deoxycytidine analogue• Inhibits reverse transcriptase and DNA
polymerase in HBV.• Systemic toxicity is low, and is well tolerated.• Resistance rapid• Used in combination with other ARVs• Chronic hepatitis B(100mgOD), HIV 1 & 2
(150mg/BD)• Zalcitabine, Lamivudine inactive each other
![Page 23: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/23.jpg)
• Other nucleoside analogs: Didanosine, Stavudine, Zalcitabine
(MOA is same as zidovudine)• Zalcitabine is no longer used due to its neurotoxic
effects • Didanosine : Purine analogue, acid liable, dose
depended pancreatitis • Stavudine : Thymidine analogue (30-40mg BD)
peripheral neuropathyLamvidine + zudovidine synergetic action
![Page 24: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/24.jpg)
NRTIs
Drug Oral Bv Distribution/PB Half life
Zidovidine 60-65% All tissues 35-38% 1-3
Stavudine 85-90% Less PB 1.2
Lamivudine 85-90% CSF 20% 35%PB 5-7
Abacavir 83% CSF33%, 50% PB 1.5
Zalcitabine >80% CSF 20%,< 4% PB 2
Emtricitabine 93 <4% PB 10
diadanoside 42 CSF 20%,< 5% PB 1.5
![Page 25: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/25.jpg)
Nucleotide Reverse Transcriptase Inhibitors (NtRTIs) Tenofovir
• In the same class of drugs as NRTIs • These are not required to be phosphorylated after they
enter the cell.• ADENOSINE analogue • Pro drug hydrolyzed in liver • Same mechanism of action as NTRIs• 300mg once daily after meals • Used in combination with NRTIs and PI • Toxicity: rash • Contraindication :- Used with caution in renal disease
patients (stone formation)
![Page 26: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/26.jpg)
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
• Inhibitors of the viral enzyme reverse transcriptase
• The drug binds to the viral enzyme at other than the active site
• changes the conformation of the active site so dec. enzyme’s affinity for nucleoside binding.
• This class of drugs works by non-competitive inhibition
![Page 27: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/27.jpg)
Nevirapine
• Binding to RT and direct inhibition at a site• Used in combination. • Main adverse effect is rash (75%).• More potent against HIV-I.• Single dose 200mg can prevents the transmission
of HIV from mother to newborn when administrate to women at onset of labour.
• Followed by oral dose of 2mg/kg to neonate with in 3days of delivery.
![Page 28: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/28.jpg)
NNRTIs
Drug Oral BV Distribution/PB Half life
Nevirapine 90-95 Wide, CSF 45%PB 60%
25-30
Efavirenz 50 CSF 1%PB 99%
40-45
Delavirdine(only for HIV I)
85 CSF 0.4%PB 98%
6
![Page 29: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/29.jpg)
Protease Inhibitors
• Reduces the number of new of infection in susceptible cells
• To be effective must be prolonged, profound and constant.
• Pharmacokinetics important to maintain constant concentrations within the effective range
• Metabolic adverse effects (DM, hyperglycemia) and GI (diarrhea, pain vomiting).
![Page 30: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/30.jpg)
Protease inhibitor• Drugs :
• Saquinavir• Ritonavir • Indinavir • Nelfinavir
• Mechanism: inhibit precursor molecules convert to mature virions during HIV replication
![Page 31: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/31.jpg)
Protease Inhibitors
• These work by competitive inhibition of the viral enzyme protease
• These drugs irreversibly bind to the active site of protease preventing it from completing the maturation of the virion
• Core is produced by proteolytic cleavage of HIV gag and pol polyprotines. It inhibits maturation and function of protiens
![Page 32: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/32.jpg)
PIsDrug BV Distribution/ PB Half life
Saquinavir -S 13 Wide, 97% PB 11
ritonavir 75 98% PB 3-5
Lopinavir Variable 98-99% PB 5-6
Nelfonavir Variable 98-99% PB 4-5
Indinavir 65 CSF 76% , PB 60% 1.8
Amprenavir 63 90% PB 7-11
Atazanavir >70 CSF 76% , PB 86% 7
![Page 33: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/33.jpg)
January 2011 33www.aidsetc.org
Adverse Effects: PIs
• All PIs: – Hyperlipidemia – Lipodystrophy – Hepatotoxicity– GI intolerance– Possibility of increased bleeding risk
for hemophiliacs– Drug-drug interactions
![Page 34: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/34.jpg)
Fusion Inhibitors
• Newest Class of Drugs
• This drug binds to the glycoprotein gp41 in the viral envelope inhibiting its fusion with the CD4+ receptor on the host cell and thus preventing the cell’s infection.
• Usually used as a last line option for most patient because it is only available as an injection and its high cost
![Page 35: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/35.jpg)
Fusion Inhibitors vs. Other Classes of Drugs
![Page 36: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/36.jpg)
January 2011 36www.aidsetc.org
Adverse Effects: Fusion Inhibitor
• ENF – Injection-site reactions– Increased risk of bacterial pneumonia
![Page 37: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/37.jpg)
Popular drug combinations
• Indinavir+ Zidovidine+ Lamivudine• Nelfinavir+ Zidovidine+ Diadinosine• Saquinavir+ Zidovidine+ Zalcitabine• Ritonavir + Lopinavir + Stavudine + Lamivudine• Ritonavir+ Indinavir + Stavudine + Diadinosine• Amprenavir + Zidovidine+ Lamivudine
![Page 38: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/38.jpg)
Combinations should not be use
• Atazanvir + Indinavir: Inc. unconjugated hyperbilirubinemia
• Didanosine/ Stavudine+ Zalcitabine: peripheral neuropathy
• Lamivudine+ Zalcitabine: In vitro antagonism
• Zidovidine+ Stavudine: Pharmacological antagonism both compete for phosphorylation
![Page 39: 13. anti retroviral](https://reader034.fdocuments.net/reader034/viewer/2022051209/5487722eb47959dd0c8b54b2/html5/thumbnails/39.jpg)